Skip to main content

DLMAF · Dollarama Inc. · Short Interest

Track DLMAF — free
$151.72 +3.87 (+2.62%) At close · Nov 2 Q2 2026 earnings call transcript
Market Cap
$40.26B
Shares
2.68B
Volume · Nov 2 62.6K Avg daily vol (3M) 56.1K

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

DLMAF Latest Reported Short Interest

FINRA reported 2,541,229 DLMAF shares sold short as of the October 15, 2026 settlement date, a decrease of 62,947 shares. Days to cover was 75.33 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 Scheduled
FINRA publishes Nov 10
— — — —
2026-10-15 2,541,229 2,604,176 -62,947 75.33
2026-09-30 2,604,176 2,901,266 -297,090 29.64
2026-09-15 2,901,266 2,991,358 -90,092 61.24
2026-08-31 2,991,358 2,986,006 +5,352 59.61
2026-08-14 2,986,006 2,639,247 +346,759 160.26
2026-07-31 2,639,247 2,106,321 +532,926 71.53
2026-07-15 2,106,321 2,001,173 +105,148 76.97
2026-06-30 2,001,173 1,425,534 +575,639 19.55
2026-06-15 1,425,534 1,712,516 -286,982 175.80
2026-05-29 1,712,516 1,705,948 +6,568 265.67
2026-05-15 1,705,948 1,669,711 +36,237 999+
2026-04-30 1,669,711 2,006,904 -337,193 385.70
2026-04-15 2,006,904 1,664,172 +342,732 72.66
2026-03-31 1,664,172 1,799,152 -134,980 472.91
2026-03-13 1,799,152 1,799,845 -693 176.73
2026-02-27 1,799,845 1,900,127 -100,282 218.99
2026-02-13 1,900,127 2,087,374 -187,247 744.86
2026-01-30 2,087,374 1,966,580 +120,794 999+
2026-01-15 1,966,580 1,954,791 +11,789 66.91
2025-12-31 1,954,791 2,266,977 -312,186 666.25
2025-12-15 2,266,990 2,277,463 -10,473 497.04
2025-11-28 2,277,463 2,295,228 -17,765 99.52
2025-11-14 2,357,352 2,644,459 -287,107 127.19

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 2073893 CUSIP 25675T305 Visit website Investor relations